[219+ Pages Report] According to Facts and Factors' most recent research and survey study, the global diabetic foot ulcer treatment market was valued at over USD 8.7 Billion in 2020 and is predicted to reach USD 12.3 Billion by 2026, rising at a remarkable 7.9% CAGR between 2021 and 2026.
Diabetic foot ulcer is a medical premonition that presents unwarranted effects of uncontrolled diabetic preconditions running rampant in the body over longer periods of time. The major underlying causes for diabetic foot ulcer treatment are peripheral neuropathy and ischemia rooted from peripheral vascular diseases. Diabetic foot ulcers occur in at least 15% of patients suffering from diabetes and generally occur in the form of an open wound. The location of the wound can vary, however, it is often located at the bottom of the foot, i.e. is the sole.
The major driving factors behind the significant growth of diabetic foot ulcer treatment market are rise in population suffering from diabetic preconditions and growing geriatric population worldwide. The increasing option for treatment coupled with increased government incentive and spending toward R&D along with rise in healthcare expenditure will further propel the growth of the diabetic foot ulcer treatment market. Factors pertaining to growth include rise in aged population, sedentary lifestyle, and an increase lifecycle of diabetes mellitus will further push the growth of the market during the forecast period. Increased awareness about treatment options among the emerging economies is projected to boost the growth of the diabetic foot ulcer treatment option toward a significant growth rate.
Moreover, factors such as a rise in adoption of treatment options such as novel therapeutics, improved biologics, and continuous prioritization of treatment to avoid surgeries also fuel the growth of the diabetic foot ulcer treatment market. The rapid growth of diabetic foot ulcers and a rising need for novel wound care devices to proportionate their suffering will further drive the growth of the market and open new revenue opportunities. However, high cost of such treatment options can hinder the growth of the market to a certain extent over the forecast timeframe. Additionally, lack of significant knowledge and equipment to deal with diabetic foot ulcer disorders, will further drive the growth of the market toward a downwards spiral.
The global diabetic foot ulcer treatment market can be segmented on the basis of types of treatment, types of ulcers, end-users, and regions.
The global diabetic foot ulcer treatment market can be divided into wound care dressings, biologics, therapy devices, antibiotics medications, and others on the basis of types of treatment. The wound care dressing can be further disintegrated into alginate dressings, hydrofiber dressings, foam & film dressings, surgical dressings, and hydrocolloid dressings and the biologics can be further broken down into growth factors and skin grafts. The therapy device segment can be further split between negative pressure wound therapy and ultrasound therapy. The wound care segment is expected to witness the highest market share during the advent of the forecast period owing to factors such as increased R&D of key players among the market, rise of technologically advanced products and increased awareness within consumers. The global diabetic foot treatment market can be segmented into neuropathic ulcers, ischemic ulcers, and neuro-ischemic ulcers on the basis of types of ulcers. The neuro-ischemic ulcer segment is expected to witness the highest market share during the forecast owing to a higher prevalence of formation coupled with higher treatment costs. The global diabetic foot ulcer treatment market can be divided into hospitals, long term care centers, specialty centers, clinics, and ambulatory surgical centers on the basis of end-users. The hospital segment will witness the highest market share owing to contributing factors such as enlarged dominance of hospital and higher adoption rate of diabetic foot ulcer treatments.
Report Attribute |
Details |
Market Size in 2020 |
USD 8.7 Billion |
Projected Market Size in 2026 |
USD 12.3 Billion |
CAGR Growth Rate |
7.9% CAGR |
Base Year |
2020 |
Forecast Years |
2021-2026 |
Key Market Players |
3M Healthcare, Coloplast A/S, Smith & Nephew Plc., B. Braun Melsungen AG, Molnlycke Health Care AB, BSN Medical GMBH, Integra LifeSciences Corporation, and Cardinal Health. |
Key Segment |
By Type of Treatment, Type of Ulcers, End-User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
North America is expected to witness the highest market share during the forecast period in terms of global revenue generation. Factors pertaining to an increase in diabetic patients and proportional healthcare facilities scattered across the region will enable the growth of the diabetic foot ulcer treatment highly predictable. Long term investment with regards to diabetic foot ulcers and a range of advanced products will further boost the growth of the market in the region. The region of Europe is expected to occupy the next subsequent position in the market in terms of volumes followed by Asia-Pacific. Asia-Pacific is expected to witness the highest CAGR growth during the forecast period due to factors such as increased prevalence of diabetes and a larger population base in emerging economies such as China and India.
The key participants in the global diabetic foot ulcer treatment market are :
Copyright © 2023 - 2024, All Rights Reserved, Facts and Factors